About the Foundation

Fero Foundation is a private entity dedicated to the promotion of cancer research. Founded in 2001 by Dr. José Baselga, Fero Foundation supports translational research, a model based on the transmission of results obtained through basic research to clinical applications, enabling patients to benefit sooner from scientific advances against cancer.

The entity supports, the Vall d’Hebron Institute of Oncology (Vall d’Hebron Instituto de Oncologia, VHIO), the Research Foundation of the Hospital Clínico de Valencia (INCLIVA) or the Prostate Cancer Lab at the Hospital 12 de Octubre, among other centers of excellence in Spain.

Mission

Our mission is to promote research aimed at eradicating cancer as a cause of death

Vision

To foster and catalyse translational oncological research in Spain

Strategic Objectives

  • To promote the creation of support infrastructures at research centres and hospitals, in order to facilitate the development of high-quality, applied oncological research.
  • To support the professional careers of our best researchers through competitive backing of excellent projects in the field of cancer.
  • To foster a FERO scientific community which can lead cancer research and treatment in Spain.

Values

  • Scientific rigour
  • Transparency
  • Independence
  • Passion
  • Social commitment towards the community (patients, donors and researchers)
  • Sustainability
  • Teamwork

What makes us different?

  • We are pioneers in the promotion of translational oncological research in Spain.
  • Our activities focus on promoting and financing cancer research.
  • We collaborate with a multidisciplinary team of specialists who guarantee excellence.
  • We support tangible projects which benefit patients directly.
  • We support research talent in the field of oncology.

Chronology

  • 2001

    Foundation of Fero
  • 2007

    Foundation of VHIO
  • 2008

    • Piru Cantarell appointed Director of the Foundation

    • Financing of the Breast Cancer Centre at Vall d’Hebrón University Hospital

    • Leopoldo Rodés appointed President

  • 2009

    Award of 1st Fero Grant in Barcelona to Dr. Jaume Mora, from Sant Joan de Déu Hospital in Barcelona
  • 2010

    Start-up Dr. Laura Soucek
  • 2012

    • Dr. José Baselga appointed President

    • Financing of a sequencer at VHIO

  • 2014

    Award of 1st Fero Grant in Madrid to Arkaitz Carracedo, from CICBioGune in Bilbao
  • 2015

    • Start-up Dr. Maria Abad

    • Start-up Dr. Sandra Peiró

  • 2016

    Financing of a sequencer at Ramón y Cajal Hospital in Madrid
  • 2017

    • Dr. Rubén Ventura joins the Foundation as Scientific Director

    • Financing of a flow cytometer at Ramón y Cajal Hospital in Madrid

  • 2018

    • Start of IRONMAN international registry in collaboration with Movember Foundation

    • Advanced Molecular Diagnostic Program

  • 2019

    • Agreement with INCLIVA in Valencia

    • 10th anniversary of Fero Grants

    • Sol Daurella appointed President

    • Creation of the Scientific Advisory Committee, chaired by Dr. Josep Tabernero

  • 2020

    • Award of 1st FERO-ASEICA Grant in Santiago de Compostela, to Dra. Cristina Mayor-Ruiz, Institute for Research in Biomedicine (IRB) Barcelona

The Foundation in figures

18

Million
invested in research


+50

Translational
research projects financed


30

Grants
Awarded to young researchers


20

Research centres
Collaborate with us